| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |